Antibodies against glycoprotein 2 display diagnostic advantages over ASCA in distinguishing CD from intestinal tuberculosis and intestinal Behçet's disease-Reference-Cited by-同舟云学术

Antibodies against glycoprotein 2 display diagnostic advantages over ASCA in distinguishing CD from intestinal tuberculosis and intestinal Behçet's disease

Published:2018-02 Issue:2 Volume:9 Page:e133
ISSN:2155-384X
Container-title:Clinical and Translational Gastroenterology
language:en
Short-container-title:

Author:

Zhang Shulan,Luo Jing,Wu Ziyan,Roggenbuck Dirk,Schierack Peter,Reinhold Dirk,Li Ji,Zeng Xiaofeng,Zhang Fengchun,Qian Jiaming,Li Yongzhe

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology

Reference35 articles.

1. Diagnosis and classification of crohns disease.;Laass;Autoimmun Rev,2014

2. Diagnosis and classification of ulcerative colitis.;Conrad;Autoimmun Rev,2014

3. Inflammatory bowel disease.;Abraham;The New England journal of medicine,2009

4. Differentiating intestinal tuberculosis from crohns disease: A diagnostic challenge.;Almadi;The American journal of gastroenterology,2009

5. Intestinal behcet and crohns disease: Two sides of the same coin.;Valenti;Pediatric rheumatology online journal,2017

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence and Clinical Relevance of Anti-FcεRI Autoantibody in Crohn’s Disease;Journal of Asthma and Allergy;2024-09

2. New diagnostic strategies to distinguish Crohn's disease and gastrointestinal tuberculosis;Current Opinion in Infectious Diseases;2024-08-06

3. From ASCA breakthrough in Crohn's disease and Candida albicans research to thirty years of investigations about their meaning in human health;Autoimmunity Reviews;2024-02

4. A Multiparametric Method Improves the Serological Characterization of Inflammatory Bowel Diseases: Preliminary Results from a Multicenter Eastern Europe Study;Gastrointestinal Disorders;2024-01-29

5. Clinical validation of serum immunosignatures in early diagnosis of Crohn's disease;iLABMED;2023-12